Ga naar de inhoud
Radio Logo
PodcastsLevenswetenschappenThe MedTech Podcast

The MedTech Podcast

Karandeep Singh Badwal
Nieuwste aflevering

109 afleveringen

  • The MedTech Podcast

    #109 Predicting Heart Attacks 90 Days Early with Michal Gutman: Building AI Patients Can Trust, Why Clinical Evidence Wins Contracts and the Heart Symptoms Women Miss

    10-11-2026 | 23 Min.
    Michal Gutman, Chief Technology and Product Officer at Hello Heart, an AI heart health platform combining connected devices, behavioural science and predictive AI with one bold goal: make heart attack and stroke a thing of the past. A founding team member who came from cybersecurity and consumer tech, including Trusteer before its acquisition by IBM, Michal leads the teams building and scaling Hello Heart’s products.

    In this episode, Michal tackles the hardest problem in prevention, getting people to care about something that might not happen for years. She explains why Hello Heart focuses on being useful today rather than chasing screen time, why she is wary of the word engagement and how a connected pillbox that lights up at home can beat the most polished push notification.

    We then get into the technology. Michal breaks down the prediction model that flags heart attack and stroke risk 90 days in advance when traditional calculators work on ten year windows, and how Nia, their AI assistant, deliberately separates natural conversation from clinical reasoning. No open web, only American College of Cardiology and American Heart Association guidance, a clinical team setting the safety boundaries and a human in the loop. We also cover where the FDA line sits for software sitting on top of a cleared device and why every feature, marketing line and in-app phrase goes through review.

    Finally, we explore why Hello Heart invested in publishing outcomes across 100,000 members in JAMA, how claims data showing a 47% reduction in hospital days helps win and keep employer contracts and why heart attack symptoms in women often look nothing like the classic image. Michal also shares how an in-house AI ops team helped her company grow productivity almost five times without growing headcount and closes with blunt advice for leaders: don’t outsource AI.

    Timestamps
    [00:01:53] From Cybersecurity to Building a Heart Health Platform
    [00:03:46] Getting People to Care About a Problem They Can’t Feel Yet
    [00:05:49] Predicting Heart Attack and Stroke 90 Days in Advance
    [00:09:14] How Nia Separates Conversation From Clinical Reasoning
    [00:10:49] Where the FDA Line Sits for AI Built on a Cleared Device
    [00:12:13] Why Publishing Outcomes on 100,000 Members Pays Off
    [00:14:02] The Heart Attack Symptoms Women Often Miss
    [00:17:17] Rolling Out AI Internally and Growing Productivity Five Times
    [00:21:25] Why Feeling Healthy and Being Healthy Are Not the Same
    [00:25:08] Value-Based Care and the Future of Prevention in the US

    Connect with Dan - ⁠⁠https://www.linkedin.com/in/michalgutman/
    Learn more about Patient.com - https://www.helloheart.com/
    Get in touch with Karandeep Badwal - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Follow Karandeep on YouTube - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Medical device training courses delivered by Karandeep through Bywater - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.bywater.co.uk/
  • The MedTech Podcast

    #108 The Trillion Dollar Admin Problem with Dan: Putting Patients at the Centre of US Healthcare, the Letter That Changed Everything and Why Timing Beats Ideas

    28-10-2026 | 23 Min.
    Dan, founder of Patient.com and a healthcare technology entrepreneur with over 30 years in the industry and five companies behind him, including Search America, now used in around 3,500 hospitals across the US.

    In this episode, Dan takes us back to where it all started. A telecoms job with a debt collection trade association revealed that most of that industry’s revenue came from healthcare, and the reason was simple: data in healthcare does not flow the way it does everywhere else. That insight pulled him into revenue cycle software and set the course for his entire career.

    The turning point came from a letter. A cancer patient wrote to thank Search America after a hospital clerk told her she qualified for full financial assistance, something she never knew. She had waited a year before going in, by which point her cancer had progressed. That moment convinced Dan the software belonged in the hands of patients, not just hospital staff, and it became the seed for Patient.com.

    We get into how Patient.com works, why consent and trust had to be built in from day one, how AI is used to translate what Dan calls healthcare speak into plain language and where the line sits between an admin platform and a regulated product. Dan also explains why his first attempt ten years ago failed because consumers simply were not ready, how Patient.com plugs into the existing plumbing of healthcare rather than replacing it and why roughly a trillion dollars of US healthcare spend is lost to administrative waste that rarely makes the news.

    Timestamps
    [00:02:00] Why She Gave Up a Faculty Position Most Scientists Chase
    [00:03:32] Learning to Be a Founder Before Making the Leap
    [00:05:38] Epitranscriptomics Explained in Plain Terms
    [00:09:07] The Prodromal Phase and Detecting MS Before Symptoms
    [00:11:31] Why Reimbursement Is Built for Reactive Medicine
    [00:13:45] What Most People Do Not Understand About Living With MS
    [00:15:20] Could This Replace the Spinal Tap and Repeat MRIs?
    [00:17:39] The Operational Chaos Nobody Warns First-Time Founders About
    [00:19:48] Why So Many Life Science Investors Will Not Touch Diagnostics
    [00:22:30] Why Nobody Has Done This Before: Sample Access as a Moat

    Connect with Dan - ⁠https://www.linkedin.com/in/daniel-johnson-ceo
    Learn more about Patient.com - ⁠⁠⁠⁠https://patient.com
    Get in touch with Karandeep Badwal - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Follow Karandeep on YouTube - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Medical device training courses delivered by Karandeep through Bywater - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.bywater.co.uk/
  • The MedTech Podcast

    #107 Catching Disease Five Years Early with Caroline Vissers: Walking Away From Faculty, Why Investors Avoid Diagnostics and Rethinking When We Diagnose

    29-09-2026 | 26 Min.
    Caroline Vissers, co-founder of Immunectra and a former UCSF faculty member, who walked away from a lab of her own to build a company. Working alongside scientific co-founders Joe DeRisi and Michael Wilson, Caroline is developing blood-based tests capable of detecting autoimmune disease long before a patient ever shows symptoms.
    In this episode, Caroline shares why she gave up a faculty position most scientists spend a career chasing, how she prepared for the jump with a venture capital course and consulting work before committing and why the entrepreneurial path was always the real destination. She also breaks down epitranscriptomics in plain terms and explains the unusual path that led from RNA methylation research into autoimmunity.
    The core of the conversation is early detection. Caroline explains the prodromal phase, why MS patients often wait years for a diagnosis while irreversible neurological damage is already happening and what it means to detect disease up to five years before onset. We get into the uncomfortable reality that healthcare reimbursement is built for reactive medicine rather than prediction, how employer-based insurance may open the door and why she is upfront that policy will have to catch up with the science.
    We also cover the access to biobanked military samples that made the discovery possible and now serves as a competitive moat, why so many life science investors avoid diagnostics entirely and Caroline's advice for anyone weighing up a leap into founding a company.
    Timestamps
    [00:02:00] Why She Gave Up a Faculty Position Most Scientists Chase
    [00:03:32] Learning to Be a Founder Before Making the Leap
    [00:05:38] Epitranscriptomics Explained in Plain Terms
    [00:09:07] The Prodromal Phase and Detecting MS Before Symptoms
    [00:11:31] Why Reimbursement Is Built for Reactive Medicine
    [00:13:45] What Most People Do Not Understand About Living With MS
    [00:15:20] Could This Replace the Spinal Tap and Repeat MRIs?
    [00:17:39] The Operational Chaos Nobody Warns First-Time Founders About
    [00:19:48] Why So Many Life Science Investors Will Not Touch Diagnostics
    [00:22:30] Why Nobody Has Done This Before: Sample Access as a Moat

    Connect with Sandy - https://www.linkedin.com/in/caroline-vissers-b7431285/
    Learn more about Immunecetra - ⁠https://qb3.org/invoke-bio-immunectra-win-100k-qb3-mentoring-awards-for-precision-cancer-vaccines-ms-diagnostic/
    https://qb3.org/im-all-in-immunectras-founder-left-her-faculty-position-to-form-groundbreaking-company/
    Get in touch with Karandeep Badwal - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Follow Karandeep on YouTube - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Medical device training courses delivered by Karandeep through Bywater - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.bywater.co.uk/
  • The MedTech Podcast

    #106 What Notified Bodies Actually Look For with Sandy Wright: Why SaMD Submissions Fail, the EU AI Act and Getting to Market Faster

    31-08-2026 | 25 Min.
    Sandy Wright, Head of Devices at Scarlet, the first notified body built specifically around software as a medical device. A former doctor who moved from clinical practice into digital health. Sandy now sits on the assessment side of the table, reviewing the very submissions most manufacturers dread putting together.
    In this episode, we start with the question that trips up so many companies. What actually turns a piece of software into a medical device and why is the wellness boundary still so blurry that entire businesses are straddling the divide without realising it. Sandy shares some of the more unusual examples out there, including AI ambient scribes and augmented reality tools that let surgeons revisit patient scans mid-operation.
    We then go inside Scarlet itself. Sandy explains why they see themselves as a technology company first and a notified body second, how a combination of expertise, redesigned process and their own internal tooling means customers are not sitting at the back of a queue for months and what genuinely drives faster conformity assessment.
    The most valuable part for anyone in this space is Sandy's breakdown of where nonconformities actually come from. Clinical evaluation, post-market clinical follow up treated as an afterthought, incomplete software requirements and risk analyses that are too narrow. We also cover the EU AI Act and how it may or may not intersect with MDR, what makes a genuinely good PCCP and Sandy's parting advice on the underrated power of narrative in a regulatory submission.
    Timestamps
    [00:01:00] What Actually Turns Software Into a Medical Device
    [00:03:39] AI Scribes and AR Headsets: SaMD You Might Not Expect
    [00:06:10] Why Scarlet Sees Itself as a Technology Company First
    [00:08:43] How Scarlet Cut Assessment Timelines Without Cutting Corners
    [00:12:12] Clinical Evaluation: The Most Common Source of Findings
    [00:13:18] Why Post-Market Clinical Follow Up Is Treated as an Afterthought
    [00:16:20] Risk Management and Why a Narrow Lens Causes Problems
    [00:16:55] The EU AI Act and How It May Intersect With MDR
    [00:19:56] From Foundation Doctor to Babylon Health and Beyond
    [00:22:42] What Separates a Good PCCP From a Box-Ticking One

    Connect with Sandy - https://www.linkedin.com/in/wrightsandy/
    Learn more about Scarlet - https://www.scarlet.cc/
    Get in touch with Karandeep Badwal - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Follow Karandeep on YouTube - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Medical device training courses delivered by Karandeep through Bywater - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.bywater.co.uk/
  • The MedTech Podcast

    #105 Inside the Transplant Industry with Tom Daulton: The Device Keeping Donated Organs Alive, Why the US Dominates Transplants and Building in a Niche Market

    17-08-2026 | 27 Min.
    Tom Daulton, CEO of Organ Recovery Systems, who has spent over 40 years in interventional medicine and building healthcare companies. Twelve months ago he knew very little about the transplant world. Today he runs one of the most fascinating businesses in it.
    In this episode, Tom explains what makes transplant unlike anything else in medicine, a field where sadly a patient has to die for another to live and where there is no pharmaceutical fallback the way dialysis can bridge a failing kidney. He breaks down why over 80% of transplants happen in the US, why the real bottleneck is donor supply rather than surgical capacity and how organs actually move across the country against a ticking clock.
    We get into the technology at the heart of the business, the egg-shaped hypothermic perfusion device roughly the size of a carry-on that keeps a donated organ stable and monitored for over 24 hours, GPS telemetry and all, a world away from the cardboard box of ice that used to be standard. Tom walks us through what an organ procurement facility looks like from the inside, why each organ needs its own dedicated device and what is coming next after kidney and liver.
    Finally, Tom shares hard-won advice for anyone building in a small niche market with real emotional weight, why you have to hire the experts, why falling in love with your product is a trap and why every niche business has to prove it is safer, faster, cheaper or better for outcomes. He closes on the tagline he lives by: be hungry and humble.
    Timestamps
    [00:01:35] From 40 Years in Interventional Medicine to the Transplant World
    [00:03:53] The Business Where a Patient Has to Die for Another to Live
    [00:05:11] Why Over 80% of Transplants Happen in the US
    [00:07:38] Not Enough Facilities or Not Enough Donors?
    [00:09:16] Inside the Egg: What the Perfusion Device Actually Does
    [00:13:28] How Organs Were Moved Before: A Cardboard Box of Ice
    [00:15:10] How Much Time the Machine Really Buys
    [00:17:20] Inside an Organ Procurement Facility
    [00:22:04] Why Every Organ Needs Its Own Device
    [00:29:11] Final Advice: Be Hungry and Humble

    Connect with Tom - ⁠⁠https://www.linkedin.com/in/tom-daulton-7230367/
    Learn more about Organ Recovery Systems - https://www.organ-recovery.com/
    Get in touch with Karandeep Badwal - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Follow Karandeep on YouTube - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
    Medical device training courses delivered by Karandeep through Bywater - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.bywater.co.uk/
Meer Levenswetenschappen podcasts
Over The MedTech Podcast
The MedTech Podcast shares the journey behind the path of the people shaping the MedTech industry and its future. Join me as I connect with industry leaders, thought providers and innovators. Hosted by Karandeep Singh Badwal, Karandeep is a Quality & Regulatory Consultant specialising in the MedTech Industry. If you have any ideas for future episodes or would like to be on the podcast then feel free to connect with me via the links below Follow Karandeep on LinkedIn: https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube: https://www.youtube.com/c/KarandeepBadwal/
Podcast website

Luister naar The MedTech Podcast, Stuff To Blow Your Mind en vele andere podcasts van over de hele wereld met de radio.net-app

Ontvang de gratis radio.net app

  • Zenders en podcasts om te bookmarken
  • Streamen via Wi-Fi of Bluetooth
  • Ondersteunt Carplay & Android Auto
  • Veel andere app-functies